Agilent Announces Target Enrichment Manufacturing Facility in China
Customers will benefit from reduced delivery time for next generation sequencing (NGS) products SANTA CLARA, Calif., August 03, 2021 Agilent Technologies Inc. (NYSE: A) today announced that it has established in-country manufacturing for its SureSelect portfolio at its facility in Hangzhou, China. Agilent is a leading provider of next-generation sequencing assays, and customers often develop... Read more